Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00121927 · ClinicalTrials.gov registry record · NA

Use of the Atkins Diet for Adults With Intractable Epilepsy

A NA study of Epilepsy, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00121927 is a NA study of Epilepsy that has completed, run by Johns Hopkins University. The registered enrollment target is 30 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00121927, a NA study of Epilepsy, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a prospective study to determine whether the Atkins diet reduces seizures, creates ketosis, and is well tolerated in adults with epilepsy. Approximately 30 patients will be enrolled, expecting 20 to complete the 6-month study. The investigators plan to establish the seizure baseline and type, initiate the Atkins diet, then monitor its administration in terms of seizure reduction, ketosis, and side effects for a 6-month period.

Conditions Studied

Epilepsy

Interventions

  • BEHAVIORAL Atkins diet (15 grams/day carbohydrates)

Study Locations (1)

Maryland

  • Johns Hopkins Hospital GCRC - Baltimore

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2004-06
Est. Completion 2007-06
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00121927

The ClinicalTrials.gov registry entry for NCT00121927 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (97% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Atkins diet (15 grams/day carbohydrates) is the first listed.

NCT00121927 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00121927 about?

NCT00121927 is a clinical study titled "Use of the Atkins Diet for Adults With Intractable Epilepsy". This is a prospective study to determine whether the Atkins diet reduces seizures, creates ketosis, and is well tolerated in adults with epilepsy. Approximately 30 patients will be enrolled, expecting 20 to complete the 6-month study. The investigators plan to establish the seizure baseline and type...

What is the current status of trial NCT00121927?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2004-06. Estimated completion is 2007-06.

What conditions does trial NCT00121927 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT00121927?

The interventions under investigation include: Atkins diet (15 grams/day carbohydrates) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00121927?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00121927 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Epilepsy

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.